Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2025-12-26 @ 1:02 AM
NCT ID:
NCT03397134
Pre Assignment Details:
During the double-blind period, 857 patients were screened in the study, and 515 patients were randomized to receive treatment, including 172 patients in the placebo group and 343 patients in the Roluperidone group. Two patients who failed to meet eligibility criteria during screening, were randomized prematurely to the 32 mg Roluperidone group but were discontinued prior to receiving any study drug. Therefore, the total number of participants started is 513.
Study:
NCT03397134
Study Brief:
Results Section:
NCT03397134